Validation checklist for initial marketing authorisation applications - biologicals other than immunologicals (applicable to submissions under Regulation (EU) 2019/6)

June 20, 2022

3D rendering of a checkmark in a checkbox.

JUNE 2022

EMA/278419/2022-Rev.1

This validation checklist is used by the Agency to validate initial marketing authorization applications for pharmaceuticals and applicants should use it as a means to review in advance of their submission that standard requirements are fulfilled.

Download the Checklist

Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.

TAGS: EMA Europe Agency Alerts Regulatory Sciences

Related Articles

Small flags for the US and EU standing next to each other on a glass desk.
EMA

June 2, 2022

EMA appoints Chief Medical Officer

June 1, 2022 Steffen Thirstrup has been appointed as Chief Medical Officer of EMA. In this role, he will provide scientific leadership across EMA and its scientific committees to reinforce the...

Continue reading the blog post
Petri dish with bacteria growing.
EMA

June 21, 2022

Advice on the designation of antimicrobials or groups of antimicrobials reserved for treatment of certain infections in humans - in relation to implementing measures under Article 37(5) of Regulation

Regulatory and Procedural Guideline May 2022 EMA/CVMP/678496/2021-rev Introduction “According to Article 37(5) of Regulation (EU) 2019/6 (‘the Regulation’), the European Commission shall adopt...

Continue reading the blog post
Wayfinding signs with arrows showing 'right' and 'wrong.'
EMA

July 13, 2022

EMA Good clinical practice (GCP) inspection procedures

The Good Clinical Practice (GCP) Inspectors Working Group has developed procedures for the coordination, preparation, conduct and reporting of GCP inspections requested by the European Medicines...

Continue reading the blog post